Curis Inc (CRIS)

Curis (CRIS) Stock Price & Analysis


CRIS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.47 - $2.63
Previous Close$0.54
Average Volume (3M)534.78K
Market Cap
Enterprise Value-$29.22M
Total Cash (Recent Filing)$85.62M
Total Debt (Recent Filing)$3.94M
Price to Earnings (P/E)-0.9
May 04, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.61
Shares Outstanding96,398,360
10 Day Avg. Volume312,085
30 Day Avg. Volume534,785
Standard Deviation0.66
Financial Highlights & Ratios
Price to Book (P/B)1.41
Price to Sales (P/S)9.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.88
Enterprise Value/Gross Profit-2.95
Enterprise Value/Ebitda0.57
Price Target Upside1189.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Curis Inc’s price range in the past 12 months?
Curis Inc lowest stock price was $0.47 and its highest was $2.63 in the past 12 months.
    What is Curis Inc’s market cap?
    Currently, no data Available
    When is Curis Inc’s upcoming earnings report date?
    Curis Inc’s upcoming earnings report date is May 04, 2023 which is in 38 days.
      How were Curis Inc’s earnings last quarter?
      Curis Inc released its earnings results on Mar 13, 2023. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.13 by $0.01.
        Is Curis Inc overvalued?
        According to Wall Street analysts Curis Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Curis Inc pay dividends?
          Curis Inc does not currently pay dividends.
          What is Curis Inc’s EPS estimate?
          Curis Inc’s EPS estimate is -$0.1.
            How many shares outstanding does Curis Inc have?
            Curis Inc has 96,617,900 shares outstanding.
              What happened to Curis Inc’s price movement after its last earnings report?
              Curis Inc reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.13. Following the earnings report the stock price went down -7.937%.
                Which hedge fund is a major shareholder of Curis Inc?
                Among the largest hedge funds holding Curis Inc’s share is Maverick Capital ltd. It holds Curis Inc’s shares valued at 3M.


                  Curis Stock Smart Score

                  The Curis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Curis Inc

                  Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.


                  Top 5 ETFs holding CRIS

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold CRIS. The ETFs are listed according to market value of CRIS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Disc Medicine
                  Decibel Therapeutics
                  Black Diamond Therapeutics
                  Aeglea Biotherapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis